Midnight Commercial Insights
NHS and NIHR organisations are under increasing pressure to prioritise innovation effectively, demonstrate impact and ensure public investment translates into real world benefit.
Midnight Commercial Insights provides early, independent commercial and adoption focused insight to support better decision making. The service complements clinical, research and health economic expertise by helping organisations assess viability, prioritise confidently and reduce downstream adoption risk.
This is not delivery or procurement support. It is decision support, designed to strengthen innovation pipelines and strategic choices before significant time, funding, or organisational credibility is committed.
What We Do
1
The Challenge
Across NHS, NIHR and university innovation pipelines, commercial and adoption considerations are often addressed late in the process. By that stage, resources may already be committed and options constrained.
This can lead to:
-
Innovations progressing that struggle to achieve adoption or scale
-
Evidence generation activity misaligned with NHS decision making needs
-
Avoidable friction at procurement or implementation stage
-
Difficulty demonstrating impact, value and accountability
Early commercial insight helps organisations avoid these issues by surfacing risks, tradeoffs and priorities sooner.
2
Our Role
Midnight Commercial Insights embeds structured commercial and adoption thinking at the right point in the process.
Support typically includes:
-
Commercial insight reviews of incoming innovations, focusing on NHS fit, adoption complexity, scalability and value
-
Prioritisation input to support innovation triage and portfolio decisions
-
Targeted advisory discussions with selected innovators or internal teams
-
Portfolio level insight, identifying common risks, barriers and opportunities across innovation pipelines
All outputs are concise, written and designed to support transparent and defensible decision making.
3
How We Work
-
Independent and non-conflicted
-
Advisory only (not delivery or supplier representation)
-
Provided on a capped retainer basis with clear scope and outputs
-
Designed to integrate with existing teams and processes
-
Minimal administrative burden
This approach provides predictable access to senior commercial judgement while protecting focus and quality.
Who We help
Midnight Commercial Insights is designed for organisations responsible for innovation decision-making and translation across NHS, NIHR and University Innovation pipelines, including:
NIHR Research
(HRCs, BRCs, Arcs)
NIHR Coordinating Centres and National Programmes
NHS Trust Innovation, Strategy and Transformation Teams
Publicly funded Accelerators and Innovation Programmes
Integrated Care Boards (ICBs)
University Innovation, Enterprise and Commercialisation Teams
Organisations often engage Midnight Commercial Insights when they are:
-
Managing a high volume of inbound innovation or commercial ideas
-
Under pressure to demonstrate impact, value, or productivity
-
Uncertain which initiatives to prioritise, pause, or redirect
-
Experiencing repeated friction at later adoption, procurement, or implementation stages
-
Seeking to improve efficiency and decision quality without adding internal headcount
How We Work With Existing Teams
Midnight Commercial Insights is designed to complement, not replace, existing clinical, research, finance and innovation expertise.
The role is to add early commercial and adoption context to decision making, helping teams use their existing capabilities, processes and resources more effectively.
Outcomes and Value
Organisations engage Midnight Commercial Insights to:
Example Outputs
Depending on organisational need, outputs may include:
Written rationale to inform portfolio review and governance discussions
Concise commercial insight summaries to support triage and prioritisation decisions
Observations on adoption, scalability, or commercial risk
Thematic insight across a group of innovations or initiatives
Midnight Commercial Insights is delivered by Midnight Health Ltd, led by Jennifer Head.
The work draws on extensive experience supporting MedTech innovators, research bodies and NHS organisations to navigate commercial pathways and adoption challenges. This background provides a practical understanding of NHS decision making, procurement realities and translational risk, complementing clinical and academic expertise.
Next Steps
We would welcome the opportunity to learn more about your current priorities, productivity bottlenecks and the challenges you are facing across your innovation or commercial activity.
An initial, no-obligation, exploratory conversation provides space to discuss:
This conversation is intended to be practical and exploratory, not a sales discussion. It helps determine whether Midnight Commercial Insights could add value and, if so, where it would have the greatest impact.
Contact us by email or book a no-obligation conversation to learn more.